Videos

At SupplySide Connect New Jersey, Jim Roza explains how domestic partnerships, seed innovation, and close-to-source manufacturing are shaping more consistent, clinically relevant botanical extracts.

At SupplySide Connect New Jersey, Suresh Lakshmikanthan, PhD, Natural Remedies’ chief business officer, describes new findings on Ashwa-30 that highlight how measurable biomarkers can help practitioners tailor protocols for stress, fatigue, and physical strain.

At SupplySide Connect New Jersey, Suresh Lakshmikanthan, PhD, Natural Remedies’ chief business officer, explains how dual-standardized Ashwa-30 leverages ATP-active compounds and withanolides to deliver energy, endurance, and metabolic benefits at just 30 mg.

At SupplySide Connect New Jersey, Keely Johnson, Arjuna Natural’s vice president of sales and marketing, discusses new clinical findings on Shoden ashwagandha, including its impact on stress, sleep, and cognitive performance in women ages 30–59.

At SupplySide Connect New Jersey, Alicia Kasch, RIBUS’ vice president, discusses how Nu-FILL is addressing excipient challenges, and why formulators drive innovation.

At SupplySide Connect New Jersey, Karen Howard, the Organic & Natural Health Association’s CEO and executive director, discusses shifting industry strategy away from fragmented lobbying toward unified, consumer-focused education to drive meaningful regulatory and public health outcomes.

In the second part of this interview, Todd Harrison, Co-Chair of the FDA Group at Venable LLP, discusses how the FDA and the industry handle novel ingredients in functional foods.

In the first part of this interview, Todd Harrison, Co-Chair of the FDA Group at Venable LLP, shares insights into regulatory methods, GRAS notices, and nutrition facts labeling surrounding the lawsuit against David Protein.

The global pre-workout supplement market is currently experiencing a period of robust expansion. According to Mordor Intelligence, the market size for pre-workout supplements was valued at $21 billion in 2025, and estimated to grow from $22.5 billion in 2026 to $31.5 billion in 2031, a [compound annual growth rate] CAGR of 6.99%. This surge is driven not only by elite athletes but by a rapidly growing segment of "casual users" and consumers who prioritize performance optimization and active lifestyles. This panel aims to bridge the gap between these market trends and the rigorous science of product development by exploring innovative ingredient solutions and strategies to overcome formulation challenges so that manufacturers can deliver effective and marketable pre-workout products.

Combining clinically studied ingredients with enhanced bioavailability, at Natural Products Expo West, Asha Ramesh, Sabinsa’s CEO – Americas, highlights the growing importance of safety data, regulatory compliance, and full documentation as brands navigate increasing scrutiny in supplement development.

Women’s health, cognition, GLP-1 support, longevity, and clean-label functional foods are among the key categories influencing demand for clinically substantiated nutraceutical ingredients, notes Asha Ramesh, Sabinsa’s CEO – Americas, from the Expo West floor.

In her interview at Natural Products Expo West, Lorena Carboni, Gnosis by Lesaffre’s senior product manager, describes how Landkind is positioned for performance and recovery, with sustainability and batch consistency central to its pitch.

In her interview at Natural Products Expo West, Stacey Smith, Gnosis by Lesaffre’s senior medical affairs liaison, discusses how MyCondro’s fermentation-based chondroitin and Quatrefolic’s active folate formats are expanding formulation opportunities across joint health, fertility, healthy aging, and functional delivery systems.

In an interview at Natural Products Expo West, Sebastian Balcombe, founder and CEO of Specnova, highlights new clinical research behind RiboBeauty, a plant-based beauty-from-within ingredient designed to support skin health and reduce hair shedding across versatile delivery formats.

Sam Ricchezza, Sr. Managing Advisor, Commercial Operations at Pharma Tech Industries highlight how partnership, reliability, and flexibility are central to supporting nutraceutical brands from concept through commercialization.

In the final part of his chat at Natural Products Expo West, Brad Schwan, ADM’s VP of global category marketing, discusses how the company is addressing digestive challenges linked to GLP-1 therapies while unlocking new opportunities in food and beverage with science-backed postbiotic solutions.

In part I of his chat at Natural Products Expo West, Brad Schwan, ADM’s VP of global category marketing, explains how the company is helping brands navigate reformulation challenges and capitalize on GLP-1-driven demand with nutrient-dense, high-protein solutions that don’t compromise on taste.

In the final part of his chat at Natural Products Expo West, Todd Runestad, NXT USA’s chief storytelling officer, discusses clinical research behind TamaFlex, reflecting a broader shift toward faster-acting joint support supplements.

In part II of his chat at Natural Products Expo West, Todd Runestad, NXT USA’s chief storytelling officer, discusses emerging nutraceutical strategies—from botanical ingredients targeting NAD metabolism for longevity to digestive support products—designed for consumers using GLP-1 weight-loss therapies.

In part I of his chat at Natural Products Expo West, Todd Runestad, NXT USA’s chief storytelling officer, discusses how higher-potency shatavari extracts may enable lower doses in supplements, while supporting emerging demand for products targeting hormonal balance across women’s life stages.

In the final part his chat at Natural Products Expo West, Justin Green, PhD, EpiCor’s director of scientific affairs, discusses why formulators are exploring postbiotics for supplements, foods, and beverages, highlighting their formulation stability, links to fermentation traditions, and emerging research on gut-immune interactions.

Live from Natural Products Expo West, Shannon Coco, Senior Sales and Marketing Director with Kerry, details how current trends are translated into flavor and product innovation.

In part I of his chat at Natural Products Expo West, Justin Green, PhD, EpiCor’s director of scientific affairs, explains how postbiotics differ from probiotics and why non-living microbes are gaining attention for their ability to interact with the microbiome and support immune responses.

At Natural Products Expo West, Bryce Wylde discusses the research and mechanism of action for ThymoQuin Cortisol Support, a standardized black seed extract for stress management.

In the final part of his chat at Natural Products Expo West, Jim Roza, chief scientific officer with Layn Natural Ingredients, shares how 99% purity and flexible formats for NAD and NMN ingredients enable diverse delivery systems—from beverages and gummies to liposomal supplements—while supporting mitochondrial health and longevity-focused nutrition.

Live from Natural Products Expo West, Nutritional Outlook met with Klaus Neumann, CEO of Vitux Group, to discuss the new chewable emulsion technology from Concordix.

In part I of his chat at Natural Products Expo West, Jim Roza, chief scientific officer with Layn Natural Ingredients, explains how NAD and its precursor NMN support cellular energy, mitochondrial function, and healthy aging—driving growing interest in longevity and performance-focused supplements.

In this interview from Natural Products Expo West 2026, Katy Kinsella, Senior Business Development Manager, ProActive Health with Kerry, discusses innovations in probiotics and postbiotics.

At Natural Products Expo West, Angie Rimell, product promotions manager with Gelita, discusses how bioactive collagen peptides are helping brands deliver targeted benefits for athletic performance, recovery, and joint health in the growing sports nutrition market.

In this live interview from Natural Products Expo West 2026, Doug Brown, Vice President – Americas with Sirio Pharma, discusses how a new soft chew for eye health supports compliance and expands the reach to consumers.